{ "tag": [ "compiled" ], "id": "ocds-h6vhtk-06e904-2026-08-20T16:30:55+01:00", "date": "2026-08-20T16:30:55+01:00", "ocid": "ocds-h6vhtk-06e904", "description": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 1 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the PSR.

Written representations should be sent to wyicb-kirk.procurement@nhs.net


Proportionality and Overall Assurance
In determining the appropriate procurement route, the ICB considered whether a competitive process would deliver additional benefit. Given the continuity of need, the absence of material change, the provider's sustained performance, and the risks associated with service disruption, the ICB concluded that a competitive process would not be proportionate to the time, cost, and delivery risk involved.
Taken together, the three documents; Record of Decision Making, Service Specification and Service Review Template provide a coherent and auditable justification for the use of Direct Award Process C, demonstrating that:
* the regulatory conditions for Process C are met;
* the decision was taken lawfully, transparently, and proportionately;
* the existing provider sufficiently meets the PSR criteria; and
* continuity of a clinically effective and system beneficial service is in the best interests of patients and the wider system.
WY ICB therefore remains satisfied that the requirements of the Provider Selection Regime have been properly applied and evidenced.
The service was evaluated against the PSR Key Criteria (weighted equally) using narrative based evidence service review.

No Conflict of Interest raised

Approver: Wakefield Place Management Team & Director of Partner Relationship Management", "initiationType": "tender", "tender": { "id": "C462799", "legalBasis": { "id": "32014L0024", "scheme": "CELEX" }, "title": "NHSWYICB - Non Consultant Led Community Dermatology Service", "status": "complete", "classification": { "scheme": "CPV", "id": "85121282", "description": "Dermatology services" }, "mainProcurementCategory": "services", "description": "Non-consultant led community dermatology service for the Wakefield population", "lots": [ { "id": "1", "description": "The Contract Authority; NHS West Yorkshire Integrated Care Board intends to award a contract to an existing provider following Direct Award Process C. The authority is publishing this notice in Find a Tender in accordance with the NHS Provider Selection Regime.

Contract Period: 01/08/2026 - 31/07/2027

Contract Value: PS4,665,444. Additional information: The ICB is not required to follow direct award process A or B
The Record of Decision Making created at the time of the decision confirms that the service:
* is an existing service;
* is delivered by an existing provider - Novus Health Limited;
* is replacing a contract that is due to expire; and
* is therefore eligible in principle for Direct Award Process C.

The commissioner confirms that the proposed contracting arrangements are not changing considerably from the existing contract
The Community Dermatology Service Specification dated 01/08/2026 demonstrates that the proposed contract does not introduce any considerable change when compared with the existing arrangements.
In substance:
* the service model remains a community-based integrated pathway;
* the population, geography, referral routes, and eligibility criteria are unchanged;
* delivery remains with the existing provider, using the same delivery and service model;
* there is no expansion, reconfiguration, or transfer of material risk.
The ICB actively reviewed the proposed scope, duration, outcomes, delivery model, and risk profile against the existing contract and concluded that none of these elements met the PSR \"considerable change\" threshold. While the specification is presented in an updated format, the underlying service is materially consistent with the existing contract.
The increase in contract value does not arise from any commissioner-led expansion of service scope, specification, patient cohort, eligibility criteria, geography or contractual outcomes. The increase is wholly attributable to unplanned growth in activity driven by external factors, including elective recovery requirements, increased referral volumes and sustained system pressures within secondary care dermatology services. The providers have delivered this additional activity through the existing service model and contractual arrangements. Accordingly, whilst the financial value exceeds the PSR material change threshold, the nature of the service being delivered remains materially unchanged and the increase reflects external demand factors rather than a substantive change to the service commissioned.

Activity by Novus increased from 6,720 attendances in FY21/22 to 14,635 attendances in FY25/26, an increase of approximately 118%. This increase followed system-wide elective recovery requirements and increased referrals from secondary care pathways at Mid Yorkshire Teaching NHS Trust. The increase in contract value reflects actual demand growth and associated activity delivered rather than any expansion of the commissioned service specification.

No changes are proposed to the service specification, referral criteria, population served, service geography, contractual outcomes or delivery model

The ICB is of the view that the existing provider is satisfying the existing contract to a sufficient standard, according to the detail outlined in the contract, and also taking into account the key criteria and applying the basic selection criteria
PSR Key Criteria provides detailed, narrative based evidence demonstrating that the existing provider:
* is satisfying the current contract to a sufficient standard; and
* is likely to satisfy the proposed contract to a sufficient standard.
Commissioners considered whether the increase in contract value, in isolation, should trigger a competitive process. Having reviewed the underlying drivers of demand, commissioners concluded that the increase reflects organic growth in activity within an unchanged service model rather than a change to the commissioned service itself. The essential characteristics of the service remain unchanged.
The Service Review assesses performance against all PSR key criteria, including:
* Quality and innovation - supported by/evidenced by commissioner evaluation of outcomes, policies and procedures against expected standards and KPI's and peer benchmarking.
* Value and stewardship of public funds - demonstrated through cost effectiveness, system savings, sustainability.
* Integration, collaboration, and sustainability - reflected through partnership working, alignment with wider pathways, digital interpolation and investment.
* Access, inequalities, and choice - supported by evidence of targeted interventions, inclusive or adapted provision, reach into underserved or priority populations.
* Social value - including evaluation of local employment and staff wellbeing community capacity building, wider economic or social benefits.
The ICB considered not only historic performance, but also whether the provider's established workforce, governance arrangements, and delivery model provide assurance of continued performance under the proposed contract. The proposed contract does not introduce new delivery requirements, expanded cohorts, or increased demand beyond that already successfully managed by the provider.

Proportionality and Overall Assurance
In determining the appropriate procurement route, the ICB considered whether a competitive process would deliver additional benefit. Given the continuity of need, the absence of material change, the provider's sustained performance, and the risks associated with service disruption, the ICB concluded that a competitive process would not be proportionate to the time, cost, and delivery risk involved.
Taken together, the three documents; Record of Decision Making, Service Specification and Service Review Template provide a coherent and auditable justification for the use of Direct Award Process C. WY ICB remains satisfied that the requirements of the Provider Selection Regime have been properly applied.", "awardCriteria": { "criteria": [ { "name": "The existing provider(s) is satisfying the contract and will likely satisfy the proposed contract to a sufficient standard.", "type": "quality", "description": "100" }, { "name": "The existing provider(s) is satisfying the contract and will likely satisfy the proposed contract to a sufficient standard.", "type": "cost", "description": "0" } ] }, "hasOptions": false, "status": "cancelled" } ], "items": [ { "id": "1", "deliveryAddresses": [ { "region": "UKE45" } ], "relatedLot": "1" } ], "procurementMethod": "limited", "procurementMethodDetails": "Award procedure without prior publication of a call for competition", "procurementMethodRationaleClassifications": [ { "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL", "id": "D_REPETITION_EXISTING", "description": "New works/services, constituting a repetition of existing works/services and ordered in accordance with the strict conditions stated in the directive" } ], "procurementMethodRationale": "This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 1 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the PSR." }, "awards": [ { "id": "079636-2026-1", "relatedLots": [ "1" ], "status": "active", "suppliers": [ { "id": "GB-FTS-186009", "name": "Novus Health Limited" } ] } ], "parties": [ { "id": "GB-FTS-178294", "name": "NHS West Yorkshire Integrated Care Board", "identifier": { "legalName": "NHS West Yorkshire Integrated Care Board" }, "address": { "streetAddress": "Scorex House, West 1 Bolton Road", "locality": "Bradford", "region": "UKE4", "postalCode": "BD1 4AS", "countryName": "United Kingdom" }, "contactPoint": { "name": "Martin Pursey", "email": "wyicb-kirk.procurement@nhs.net" }, "roles": [ "buyer", "reviewContactPoint" ], "details": { "url": "https://www.westyorkshire.icb.nhs.uk/", "buyerProfile": "https://www.westyorkshire.icb.nhs.uk/", "classifications": [ { "scheme": "TED_CA_TYPE", "id": "BODY_PUBLIC", "description": "Body governed by public law" }, { "scheme": "COFOG", "id": "07", "description": "Health" } ] } }, { "id": "GB-FTS-186009", "name": "Novus Health Limited", "identifier": { "legalName": "Novus Health Limited", "id": "06076346" }, "address": { "streetAddress": "Millennium Court, 60 Queen Street Normanton", "locality": "Wakefield", "region": "UKE45", "postalCode": "WF6 2BU", "countryName": "United Kingdom" }, "contactPoint": { "telephone": "+44 7446056588" }, "roles": [ "supplier" ], "details": { "url": "http://www.novushealth.co.uk", "scale": "sme" } }, { "id": "GB-FTS-179126", "name": "WYICB PSR Review Panel", "identifier": { "legalName": "WYICB PSR Review Panel" }, "address": { "streetAddress": "Scorex House, West 1 Bolton Road", "locality": "Bradford", "postalCode": "BD1 4AS", "countryName": "United Kingdom" }, "roles": [ "reviewBody" ], "details": { "url": "https://www.westyorkshire.icb.nhs.uk/" } }, { "id": "GB-FTS-123151", "name": "NHS England Independent Patient Choice and Procurement Panel", "identifier": { "legalName": "NHS England Independent Patient Choice and Procurement Panel" }, "address": { "streetAddress": "London", "locality": "London", "postalCode": "SE1 8UG", "countryName": "United Kingdom" }, "roles": [ "mediationBody" ], "details": { "url": "https://www.england.nhs.uk/commissioning/how-commissioning-is-changing/nhs-provider-selection-regime/independent-patient-choice-and-procurement-panel/" } } ], "buyer": { "id": "GB-FTS-178294", "name": "NHS West Yorkshire Integrated Care Board" }, "contracts": [ { "id": "079636-2026-1", "awardID": "079636-2026-1", "status": "active", "value": { "amount": 4665444, "currency": "GBP" }, "dateSigned": "2026-08-10T00:00:00+01:00" } ], "bids": { "statistics": [ { "id": "1", "measure": "bids", "relatedLot": "1", "value": 1 } ] }, "language": "en" }